Back

Myosin inhibitors for treatment of hypertrophic obstructive cardiomyopathy.

26 August 2022 (09:34 - 09:47)
Organised by:
Congress Presentation Part of: The next frontiers in innovative therapies Cardiovascular Disease in Specific Populations ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Milind Desai

Cleveland Clinic, Cleveland (United States of America)

6 More presentations in this session

Presentation thumbnail
Discoveries to bedside therapies.
Professor N. Dib (Phoenix, US)
Slides Video
Presentation thumbnail
Interventional solutions for heart failure.
Professor J. Lindenfeld (Nashville, US)
Slides Video
Presentation thumbnail
Lp(a): aspirations for treating aortic stenosis.
Professor U. Landmesser (Berlin, DE)
Slides Video
Presentation thumbnail
Can we eradicate atherosclerosis?
Professor E. Braunwald (Boston, US)
Slides Video
Presentation thumbnail
Innovation in diagnosis and treatment of HFpEF.
Professor I. Pina (Philadelphia, US)
Slides Video

Access the full session

Session thumbnail
The next frontiers in innovative therapies
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 09:34 CET
You may be interested in
thumbnail
Congress Presentation
Improving quality of life in patients with hypertrophic cardiomyopathy
25 August 2023
thumbnail
Congress Session
Cardiac myosin inhibitors for treatment of hypertrophic obstructive cardiomyopathy
2 September 2024
thumbnail
Congress Presentation
Managing patients with hypertrophic cardiomyopathy: what is the therapeutic landscape.
27 August 2022
thumbnail
Congress Presentation
Spotlight on cardiac myosin inhibition
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources